Skip to main content
. 2018 Apr 25;2(1):pky009. doi: 10.1093/jncics/pky009

Table 3.

Breast, cervical, and lung cancer* incidence rate ratios (IRR) (95% confidence interval): ICE and poverty, MA city/town and census tract, 2010-2014 for the total population

ICE: income (low vs high income): IRR (95% CI)
ICE: race/ethnicity(black vs white non-Hispanic): IRR (95% CI)
ICE: race/ethnicity + income (low-income black vs high-income white non-Hispanic): IRR (95% CI)
Poverty(most vs least impoverished): IRR (95% CI)
Outcome Quintile comparisons CT City/town CT City/town CT City/town CT City/town
Breast cancer incidence (women only) Model 1 (a, b): only 1 level 1a 1b 1a 1b 1a 1b 1a 1b
Q1 (worst off) 0.86 (0.82 to 0.91) 0.86 (0.82 to 0.90) 1.01 (0.95 to 1.08) 1.09 (1.02 to 1.16) 0.89 (0.84 to 0.94) 0.86 (0.81 to 0.90) 0.88 (0.83 to 0.93) 0.90 (0.85 to 0.95)
Q2 0.86 (0.82 to 0.91) 0.90 (0.85 to 0.94) 1.04 (0.99 to 1.09) 1.11 (1.04 to 1.18) 0.88 (0.84 to 0.93) 0.90 (0.85 to 0.95) 0.91 (0.86 to 0.95) 0.93 (0.88 to 0.99)
Q3 0.92 (0.88 to 0.96) 0.87 (0.83 to 0.92) 1.05 (1.00 to 1.09) 1.09 (1.01 to 1.17) 0.91 (0.87 to 0.95) 0.90 (0.85 to 0.95) 0.95 (0.91 to 0.99) 0.94 (0.88 to 1.00)
Q4 0.94 (0.90 to 0.98) 0.92 (0.88 to 0.97) 1.05 (1.01 to 1.10) 1.02 (0.95 to 1.10) 0.96 (0.92 to 1.01) 0.93 (0.88 to 0.99) 0.97 (0.93 to 1.01) 0.98 (0.93 to 1.04)
Q5 (best off) (referent) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Model 2: both levels
Q1 (worst off) 0.89 (0.83 to 0.96) 0.93 (0.87 to 1.00) 0.95 (0.88 to 1.03) 1.11 (1.02 to 1.21) 0.94 (0.88 to 1.01) 0.91 (0.84 to 0.98) 0.91 (0.85 to 0.97) 0.95 (0.89 to 1.02)
Q2 0.90 (0.84 to 0.95) 0.95 (0.89 to 1.02) 0.98 (0.91 to 1.04) 1.11 (1.03 to 1.21) 0.93 (0.87 to 0.99) 0.93 (0.87 to 1.00) 0.93 (0.88 to 0.98) 0.96 (0.90 to 1.03)
Q3 0.95 (0.90 to 1.00) 0.90 (0.84 to 0.96) 0.98 (0.93 to 1.05) 1.09 (1.00 to 1.17) 0.95 (0.90 to 1.00) 0.92 (0.86 to 0.98) 0.97 (0.92 to 1.02) 0.95 (0.90 to 1.02)
Q4 0.97 (0.93 to 1.02) 0.94 (0.89 to 0.99) 1.01 (0.96 to 1.06) 1.02 (0.94 to 1.10) 1.00 (0.95 to 1.05) 0.94 (0.88 to 0.99) 0.98 (0.94 to 1.02) 0.99 (0.93 to 1.05)
Q5 (best off) (referent) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Cervical cancer incidence Model 1 (a, b): only 1 level 1a 1b 1a 1b 1a 1b 1a 1b
Q1 (worst off) 2.82 (2.20 to 3.63) 2.31 (1.74 to 3.05) 2.44 (1.89 to 3.15) 1.42 (1.04 to 1.94) 2.87 (2.26 to 3.65) 2.14 (1.63 to 2.81) 2.14 (1.67 to 2.74) 1.96 (1.48 to 2.58)
Q2 2.13 (1.68 to 2.71) 1.93 (1.44 to 2.58) 1.57 (1.24 to 1.99) 0.97 (0.69 to 1.36) 1.96 (1.55 to 2.48) 1.64 (1.23 to 2.19) 1.86 (1.49 to 2.32) 1.67 (1.24 to 2.25)
Q3 1.78 (1.40 to 2.26) 1.63 (1.20 to 2.21) 1.32 (1.04 to 1.67) 1.08 (0.76 to 1.53) 1.88 (1.49 to 2.37) 1.61 (1.19 to 2.16) 1.48 (1.18 to 1.85) 1.41 (1.03 to 1.93)
Q4 1.53 (1.21 to 1.95) 1.50 (1.11 to 2.03) 1.35 (1.08 to 1.70) 0.88 (0.60 to 1.30) 1.31 (1.03 to 1.66) 1.23 (0.90 to 1.67) 1.15 (0.91 to 1.45) 1.2 (0.88 to 1.65)
Q5 (best off) (referent) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Model 2: both levels
Q1 (worst off) 2.61 (1.85 to 3.67) 1.19 (0.81 to 1.73) 2.54 (1.75 to 3.68) 0.84 (0.55 to 1.29) 3.02 (2.13 to 4.27) 0.96 (0.67 to 1.38) 1.88 (1.38 to 2.55) 1.29 (0.92 to 1.82)
Q2 1.96 (1.41 to 2.72) 1.20 (0.84 to 1.74) 1.65 (1.16 to 2.36) 0.71 (0.47 to 1.07) 2.05 (1.47 to 2.86) 0.94 (0.66 to 1.34) 1.63 (1.23 to 2.16) 1.32 (0.94 to 1.85)
Q3 1.64 (1.21 to 2.23) 1.15 (0.80 to 1.64) 1.46 (1.05 to 2.04) 0.84 (0.57 to 1.25) 1.91 (1.41 to 2.60) 1.11 (0.78 to 1.57) 1.32 (1.01 to 1.71) 1.25 (0.89 to 1.75)
Q4 1.42 (1.08 to 1.87) 1.24 (0.89 to 1.71) 1.47 (1.11 to 1.95) 0.82 (0.55 to 1.21) 1.28 (0.97 to 1.71) 1.03 (0.74 to 1.43) 1.08 (0.85 to 1.38) 1.14 (0.82 to 1.58)
Q5 (best off) (referent) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Lung cancer incidence Model 1 (a, b): only 1 level 1a 1b 1a 1b 1a 1b 1a 1b
Q1 (worst off) 1.67 (1.55 to 1.79) 1.79 (1.64 to 1.96) 1.46 (1.34 to 1.58) 1.35 (1.20 to 1.51) 1.72 (1.60 to 1.85) 1.87 (1.72 to 2.03) 1.49 (1.39 to 1.60) 1.45 (1.31 to 1.60)
Q2 1.43 (1.35 to 1.53) 1.49 (1.36 to 1.63) 1.27 (1.18 to 1.36) 1.22 (1.09 to 1.37) 1.49 (1.40 to 1.59) 1.52 (1.40 to 1.66) 1.25 (1.17 to 1.33) 1.34 (1.21 to 1.48)
Q3 1.25 (1.18 to 1.33) 1.44 (1.31 to 1.57) 1.10 (1.04 to 1.18) 1.20 (1.07 to 1.35) 1.35 (1.27 to 1.43) 1.48 (1.36 to 1.61) 1.16 (1.10 to 1.23) 1.17 (1.06 to 1.30)
Q4 1.20 (1.13 to 1.27) 1.32 (1.21 to 1.45) 1.05 (0.99 to 1.11) 1.21 (1.07 to 1.37) 1.21 (1.14 to 1.28) 1.37 (1.26 to 1.49) 1.08 (1.03 to 1.15) 1.12 (1.02 to 1.24)
Q5 (best off) (referent) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Model 2: both levels
Q1 (worst off) 1.48 (1.36 to 1.61) 1.39 (1.25 to 1.55) 1.44 (1.31 to 1.59) 1.12 (0.99 to 1.28) 1.52 (1.40 to 1.66) 1.40 (1.26 to 1.55) 1.41 (1.30 to 1.53) 1.22 (1.10 to 1.36)
Q2 1.27 (1.18 to 1.37) 1.28 (1.16 to 1.42) 1.25 (1.15 to 1.36) 1.15 (1.02 to 1.30) 1.32 (1.23 to 1.43) 1.26 (1.14 to 1.39) 1.18 (1.10 to 1.26) 1.23 (1.10 to 1.37)
Q3 1.13 (1.06 to 1.22) 1.30 (1.18 to 1.44) 1.09 (1.01 to 1.17) 1.17 (1.04 to 1.33) 1.23 (1.14 to 1.32) 1.30 (1.18 to 1.43) 1.11 (1.04 to 1.18) 1.12 (1.00 to 1.24)
Q4 1.11 (1.04 to 1.18) 1.25 (1.15 to 1.37) 1.03 (0.96 to 1.10) 1.21 (1.07 to 1.36) 1.11 (1.04 to 1.18) 1.29 (1.18 to 1.41) 1.06 (1.00 to 1.12) 1.09 (0.99 to 1.21)
Q5 (best off) (referent) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
*

Model 1a includes only the census tract measure, Model 1b includes only the city/town measure, and Model 2 includes measures from both levels. All models adjust for race/ethnicity and urbanicity. The lung cancer model also adjusts for gender. All models control for age. CT = census tract; ICE = Index of Concentration at the Extremes.